525 related articles for article (PubMed ID: 31498131)
21. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
Tan AH; Chong CW; Lim SY; Yap IKS; Teh CSJ; Loke MF; Song SL; Tan JY; Ang BH; Tan YQ; Kho MT; Bowman J; Mahadeva S; Yong HS; Lang AE
Ann Neurol; 2021 Mar; 89(3):546-559. PubMed ID: 33274480
[TBL] [Abstract][Full Text] [Related]
22. The Gut and Parkinson's Disease: Hype or Hope?
Scheperjans F; Derkinderen P; Borghammer P
J Parkinsons Dis; 2018; 8(s1):S31-S39. PubMed ID: 30584161
[TBL] [Abstract][Full Text] [Related]
23. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota in Parkinson disease in a northern German cohort.
Hopfner F; Künstner A; Müller SH; Künzel S; Zeuner KE; Margraf NG; Deuschl G; Baines JF; Kuhlenbäumer G
Brain Res; 2017 Jul; 1667():41-45. PubMed ID: 28506555
[TBL] [Abstract][Full Text] [Related]
25. The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.
Mihaila D; Donegan J; Barns S; LaRocca D; Du Q; Zheng D; Vidal M; Neville C; Uhlig R; Middleton FA
PLoS One; 2019; 14(6):e0218252. PubMed ID: 31247001
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
Nuzum ND; Loughman A; Szymlek-Gay EA; Hendy A; Teo WP; Macpherson H
Neurosci Biobehav Rev; 2020 May; 112():227-241. PubMed ID: 32032654
[TBL] [Abstract][Full Text] [Related]
27. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
[TBL] [Abstract][Full Text] [Related]
28. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease.
Hegelmaier T; Lebbing M; Duscha A; Tomaske L; Tönges L; Holm JB; Bjørn Nielsen H; Gatermann SG; Przuntek H; Haghikia A
Cells; 2020 Feb; 9(2):. PubMed ID: 32041265
[TBL] [Abstract][Full Text] [Related]
29. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.
Baldini F; Hertel J; Sandt E; Thinnes CC; Neuberger-Castillo L; Pavelka L; Betsou F; Krüger R; Thiele I;
BMC Biol; 2020 Jun; 18(1):62. PubMed ID: 32517799
[TBL] [Abstract][Full Text] [Related]
30. Fecal microbiome alterations in treatment-naive de novo Parkinson's disease.
Boertien JM; Murtomäki K; Pereira PAB; van der Zee S; Mertsalmi TH; Levo R; Nojonen T; Mäkinen E; Jaakkola E; Laine P; Paulin L; Pekkonen E; Kaasinen V; Auvinen P; Scheperjans F; van Laar T;
NPJ Parkinsons Dis; 2022 Oct; 8(1):129. PubMed ID: 36216843
[TBL] [Abstract][Full Text] [Related]
31. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
32. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
Chan DG; Ventura K; Villeneuve A; Du Bois P; Holahan MR
J Parkinsons Dis; 2022; 12(8):2339-2352. PubMed ID: 36278360
[TBL] [Abstract][Full Text] [Related]
33. The gut microbiome and cognition in Parkinson's disease: a systematic review.
Grant H; Anderton R; Gasson N; Lawrence BJ
Nutr Neurosci; 2023 Oct; 26(10):932-941. PubMed ID: 35965446
[TBL] [Abstract][Full Text] [Related]
34. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
Cilia R; Piatti M; Cereda E; Bolliri C; Caronni S; Ferri V; Cassani E; Bonvegna S; Ferrarese C; Zecchinelli AL; Barichella M; Pezzoli G
J Parkinsons Dis; 2021; 11(1):159-170. PubMed ID: 33337387
[TBL] [Abstract][Full Text] [Related]
35. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
36. Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease.
Hertel J; Harms AC; Heinken A; Baldini F; Thinnes CC; Glaab E; Vasco DA; Pietzner M; Stewart ID; Wareham NJ; Langenberg C; Trenkwalder C; Krüger R; Hankemeier T; Fleming RMT; Mollenhauer B; Thiele I
Cell Rep; 2019 Nov; 29(7):1767-1777.e8. PubMed ID: 31722195
[TBL] [Abstract][Full Text] [Related]
37. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance.
Bi M; Feng L; He J; Liu C; Wang Y; Jiang H; Liu SJ
Ageing Res Rev; 2022 Dec; 82():101759. PubMed ID: 36243356
[TBL] [Abstract][Full Text] [Related]
38. Parkinson's Disease and the Gut Microbiome in Rural California.
Zhang K; Paul KC; Jacobs JP; Chou HL; Duarte Folle A; Del Rosario I; Yu Y; Bronstein JM; Keener AM; Ritz B
J Parkinsons Dis; 2022; 12(8):2441-2452. PubMed ID: 36442206
[TBL] [Abstract][Full Text] [Related]
39. Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.
van Kessel SP; El Aidy S
J Parkinsons Dis; 2019; 9(s2):S359-S370. PubMed ID: 31609701
[TBL] [Abstract][Full Text] [Related]
40. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
Fang X
Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
